A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP

NCT06838949 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Herombopag

Interventions

DRUG: herombopag olamine tablets

Sponsor

Institute of Hematology & Blood Diseases Hospital, China